andrea francesca quivelli

Dr. andrea francesca quivelli

orcid

Research Focus & Metrics

Academic Career Length

9Years (2018-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications

14 June 2023 in Angewandte Chemie International Edition
Verified
Journal Article
Open access
GDGiuseppe Dilauro
Giuseppe Dilauro
CLCosimo Luccarelli
Cosimo Luccarelli
AQandrea francesca quivelli
andrea francesca quivelli
PVPaola Vitale
Paola Vitale
FPFilippo Perna
Filippo Perna
Vito CapriatiVito Capriati
Vito Capriati
Advancing the development of perfecting the use of polar organometallics in bio‐inspired solvents, we report on the effective generation in batch of organosodium compounds, by the oxidative addition of a C−Cl bond to sodium, a halogen/sodium exchange, or by direct sodiation, when using sodium bricks or neopentylsodium in hexane as sodium sources. C(sp3)‐, C(sp2)‐, and C(sp)‐hybridized alkyl and (hetero)aryl sodiated species have been chemoselectively trapped (in competition with protonolysis), with a variety of electrophiles when working “on water”, or in biodegradable choline chloride/urea or L‐proline/glycerol eutectic mixtures, under hydrous conditions and at room temperature. Additional benefits include a very short reaction time (20 s), a wide substrate scope, and good to excellent yields (up to 98 %) of the desired adducts. The practicality of the proposed protocol was demonstrated by setting up a sodium‐mediated multigram‐scale synthesis of the anticholinergic drug orphenadrine.

23 June 2021 in Materials
Verified
Journal Article
Open access
PDF file
ATAdriana Trapani
Adriana Trapani
Filomena CorboFilomena Corbo
Filomena Corbo
Gennaro AgrimiGennaro Agrimi
Gennaro Agrimi
Nicoletta DitarantoNicoletta Ditaranto
Nicoletta Ditaranto
Nicola CioffiNicola Cioffi
Nicola Cioffi
Stefano BellucciStefano Bellucci
Stefano Bellucci
Background: The blood–brain barrier (BBB) bypass of dopamine (DA) is still a challenge for supplying it to the neurons of Substantia Nigra mainly affected by Parkinson disease. DA prodrugs have been studied to cross the BBB, overcoming the limitations of DA hydrophilicity. Therefore, the aim of this work is the synthesis and preliminary characterization of an oxidized alginate-dopamine (AlgOX-DA) conjugate conceived for DA nose-to-brain delivery. Methods: A Schiff base was designed to connect oxidized polymeric backbone to DA and both AlgOX and AlgOX-DA were characterized in terms of Raman, XPS, FT-IR, and 1H- NMR spectroscopies, as well as in vitro mucoadhesive and release tests. Results: Data demonstrated that AlgOX-DA was the most mucoadhesive material among the tested ones and it released the neurotransmitter in simulated nasal fluid and in low amounts in phosphate buffer saline. Results also demonstrated the capability of scanning near-field optical microscopy to study the structural and fluorescence properties of AlgOX, fluorescently labeled with fluorescein isothiocyanate microstructures. Interestingly, in SH-SY5Y neuroblastoma cell line up to 100 μg/mL, no toxic effect was derived from AlgOX and AlgOX-DA in 24 h. Conclusions: Overall, the in vitro performances of AlgOX and AlgOX-DA conjugates seem to encourage further ex vivo and in vivo studies in view of nose-to-brain administration.

11 November 2021 in ChemSusChem
Verified
Journal Article
Open access
PDF file
AQandrea francesca quivelli
andrea francesca quivelli
MMManuela Marinò
Manuela Marinò
PVPaola Vitale
Paola Vitale
Joaquin García ÁlvarezJoaquin García Álvarez
Joaquin García Álvarez
FPFilippo Perna
Filippo Perna
Vito CapriatiVito Capriati
Vito Capriati
An efficient and novel protocol was developed for a Cu‐catalyzed Ullmann‐type aryl alkyl ether synthesis by reacting various (hetero)aryl halides (Cl, Br, I) with alcohols as active components of environmentally benign choline chloride‐based eutectic mixtures. Under optimized conditions, the reaction proceeded under mild conditions (80 °C) in air, in the absence of additional ligands, with a catalyst [CuI or CuII species] loading up to 5 mol% and K2CO3 as the base, providing the desired aryloxy derivatives in up to 98 % yield. The potential application of the methodology was demonstrated in the valorization of cheap, easily available, and naturally occurring polyols (e. g., glycerol) for the synthesis of some pharmacologically active aryloxypropanediols (Guaiphenesin, Mephenesin, and Chlorphenesin) on a 2 g scale in 70–96 % yield. Catalyst, base, and deep eutectic solvent could easily and successfully be recycled up to seven times with an E‐factor as low as 5.76.


11 December 2023 in Sustainable Energy & Fuels
Verified
Journal Article
Open access
PDF file
CBChiara Liliana Boldrini
Chiara Liliana Boldrini
AQandrea francesca quivelli
andrea francesca quivelli
FPFilippo Perna
Filippo Perna
PBPaolo Biagini
Paolo Biagini
Vito CapriatiVito Capriati
Vito Capriati
NMNorberto Manfredi
Norberto Manfredi
This work presents the next paradigm shift in solar energy technology in which a novel iodide-based DES-like mixture has been first investigated as an active electrolyte solvent in dye-sensitized solar cells (DSSCs) in the absence of any co-solvent and any external iodide source. The optimization of the cell design jointly with a bespoke dye functionalized with a hydrophobic chain, properly positioned along the molecular backbone, ensures (a) one of the highest power conversion efficiencies (PCEs) up to 4% for DSSCs based on non-VOC solvents, and (b) a remarkable temporal stability of nearly 95% over a period longer than 2 months. Higher power conversion efficiency values (up to 8.0%) than those reported in the literature with traditional sensitizers and environmentally friendly electrolytes (e.g., water-based electrolytes) have been achieved under low-light illumination. These results are very promising for the realization of next-generation nature-inspired low-cost and high-performing DSSC devices for indoor and outdoor applications.